Aurobindo Pharma Secures US FDA Approval for Glycerol Phenylbutyrate Oral Liquid 1.1 g/mL
Aurobindo Pharma has secured USFDA approval for Glycerol Phenylbutyrate Oral Liquid 1.1 g/mL, to be manufactured at its Unit-III facility, with immediate launch planned to strengthen its specialty pharma portfolio.
Glycerol Phenylbutyrate Oral Liquid 1.1 G/mL | 17/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy